Fleming Initiative appoints Amit Mulji as inaugural Chief Operating Officer

The Fleming Initiative has appointed Amit Mulji as its first Chief Operating Officer, marking a significant milestone as the Initiative strengthens its executive team and builds the foundations to convene global partnerships in tackling antimicrobial resistance (AMR).

Amit Mulji, Chief Operating Officer of the Fleming Initiative

As Chief Operating Officer, Amit joins at a pivotal stage in the Initiative’s development –⁠ following the securing of its first £100 million in funding and entering its next phase of scaled delivery. He will lead the development of the Initiative’s operational excellence –⁠ across finance, governance, partnerships, communications and programme delivery –⁠ as the Initiative progresses the development of a landmark new Centre scheduled to launch in late 2028. His remit includes ensuring the Initiative can scale in a way that delivers meaningful and enduring impact in combating AMR.

Amit brings over a decade of experience across academia, industry and government. He previously served on the Executive Committee of The Alan Turing Institute, where he led the development of the Institute’s first strategy, secured its long-term £100 million core funding settlement, and oversaw the delivery of multi-million-pound cross-cutting programmes spanning research, skills and engagement.

Earlier in his career, he worked across a range of health policy areas and advising organisations, including those operating at the intersection of innovation, life sciences and healthcare delivery. His experience spans system design, funding strategy and organisational governance, with a focus on enabling measurable, mission-driven impact across complex stakeholder landscapes.

Professor Alison Holmes, Director of the Fleming Initiative, said:

“Appointing our first Chief Operating Officer marks an important step in our evolution as we move from establishment to scaled delivery. Amit brings rich cross-sector experience spanning strategy, operations and governance. His leadership will be critical as we strengthen our core management capabilities and global partnerships to deliver sustained impact in tackling antimicrobial resistance.”

Amit Mulji said:

“Antimicrobial resistance is a defining global health challenge, but its consequences are deeply personal for communities around the world. The seriousness of the commitment already secured reflects a shared confidence in the Initiative’s long-term impact at scale. I look forward to strengthening the collective capability required to sustainably deliver on our ambitious mission.”